Authors:
Dossenbach, MRK
Kratky, P
Schneidman, M
Grundy, SL
Metcalfe, S
Tollefson, GD
Belmaker, RH
Citation: Mrk. Dossenbach et al., Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone, J CLIN PSY, 62, 2001, pp. 28-34
Authors:
Poyurovsky, M
Nave, R
Epstein, R
Tzischinsky, O
Schneidman, M
Barnes, TRE
Weizman, A
Lavie, P
Citation: M. Poyurovsky et al., Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia, EUR NEUROPS, 10(3), 2000, pp. 171-176
Authors:
Dossenbach, MRK
Beuzen, JN
Avnon, M
Belmaker, RH
Elizur, A
Mark, M
Munitz, H
Schneidman, M
Shoshani, D
Kratky, P
Grundy, SL
Tollefson, GD
Citation: Mrk. Dossenbach et al., The effectiveness of olanzapine in treatment-refractory schizophrenia whenpatients are nonresponsive to or unable to tolerate clozapine, CLIN THER, 22(9), 2000, pp. 1021-1034
Authors:
Frisch, A
Postilnick, D
Rockah, R
Michaelovsky, E
Postilnick, S
Birman, E
Laor, N
Rauchverger, B
Kreinin, A
Poyurovsky, M
Schneidman, M
Modai, I
Weizman, R
Citation: A. Frisch et al., Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways, MOL PSYCHI, 4(4), 1999, pp. 389-392
Authors:
Poyurovsky, M
Isakov, V
Hromnikov, S
Modai, I
Rauchberger, B
Schneidman, M
Weizman, A
Citation: M. Poyurovsky et al., Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study, INT CLIN PS, 14(2), 1999, pp. 95-100
Authors:
Poyurovsky, M
Shardorodsky, M
Fuchs, C
Schneidman, M
Weizman, A
Citation: M. Poyurovsky et al., Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin - Double-blind, placebo-controlled study, BR J PSYCHI, 174, 1999, pp. 238-242